Cart
sales@molnova.com
Suritozole
CAS No. 110623-33-1
Suritozole( MDL-26479 )
Catalog No. M22215 CAS No. 110623-33-1
Suritozole is a negative modulator at the gamma-aminobutyric acidA (GABAA) receptorSuritozole is a negative modulator at the gamma-aminobutyric acidA (GABAA) receptor that enhances cholinergic function, in attenuating spatial memory deficits after traumatic brain injury in the rat.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 178 | Get Quote |
|
| 5MG | 267 | Get Quote |
|
| 10MG | 408 | Get Quote |
|
| 25MG | 672 | Get Quote |
|
| 50MG | 945 | Get Quote |
|
| 100MG | 1278 | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameSuritozole
-
NoteResearch use only, not for human use.
-
Brief DescriptionSuritozole is a negative modulator at the gamma-aminobutyric acidA (GABAA) receptorSuritozole is a negative modulator at the gamma-aminobutyric acidA (GABAA) receptor that enhances cholinergic function, in attenuating spatial memory deficits after traumatic brain injury in the rat.
-
DescriptionSuritozole is a negative modulator at the gamma-aminobutyric acidA (GABAA) receptorSuritozole is a negative modulator at the gamma-aminobutyric acidA (GABAA) receptor that enhances cholinergic function, in attenuating spatial memory deficits after traumatic brain injury in the rat.
-
In Vitro——
-
In Vivo——
-
SynonymsMDL-26479
-
PathwayOthers
-
TargetOther Targets
-
RecptorGABAA
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number110623-33-1
-
Formula Weight223.27
-
Molecular FormulaC10H10FN3S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESS=C1N(C)N=C(C2=CC=CC(F)=C2)N1C
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.O'Dell D M , Hamm R J . Chronic postinjury administration of MDL 26,479 (Suritozole), a negative modulator at the GABAA receptor, and cognitive impairment in rats following traumatic brain injury[J]. Journal of Neurosurgery, 1995, 83(5):878-83.
molnova catalog
related products
-
Tirzepatide TFA (202...
Tirzepatide TFA (LY3298176 TFA) is a disaccharide dependent insulin peptide (GIP) and glucagon-like peptide-1 (glp-1) receptor agonist.
-
Salcaprozate sodium
Salcaprozate sodium is an oral absorption promoter, and has the potential as a delivery agent for oral forms of heparin and insulin.
-
Orexin A (human, rat...
Endogenous agonist at orexin receptors (Ki values are 20 and 38 nM for OX1 and OX2 receptors respectively). Stimulates feeding following central administration and may be involved in the control of sleep-wake cycle and other hypothalamic functions.
